[September 29, 2017]

Canada In-Vitro Diagnostics Market - Growth, Trends & Forecast 2017 - 2022 - Research and Markets

The "Canada In-Vitro Diagnostics Market - Growth, Trends & Forecast 2017 - 2022" report has been added to Research and Markets' offering.

Canada's market for In-Vitro Diagnostics is currently estimated to be worth USD 8.71 billion in the year 2014 and is expected to reach USD 11.31 billion by the end of 2020. The CAGR during this period of the forecast is 5.36%.

Currently, North America dominates the global market, with the market yet to reach saturation. The Canada is the leading market both globally and in North America. Canada is the next big market in the North America region. This is due to the advances on the technology forefront and the higher GDP of the nation. This escalation is developing the need to analyze, review and forecast the growth of the In-Vitro Diagnostics market.

Some of the factors contributing to the growth of market are:

• Rapid increase in the chronic & infectious disease population
• Technological advances
• Rapidly aging population
• Advent of point of care diagnostics
• Restraints
  

Key Topics Covered:

1. Introduction

2. Research Methodology

3. Executive Summary

4. Key Inferences

5. Market Overview and Industry Trends

6. Drivers, Restraints, Opportunities, and Challenges Analysis

7. In-Vitro Diagnostics (IVD) market segmentation

8. Competitive Landscape

9. Key Vendor Analysis

10. Future Outlook of the Market

Companies Mentioned

• Abbott Diagnostics
• Bayer Diabetes Care/Panasonic (News - Alert) Healthcare
• Becton Dickinson and Company
• Biomerieux
• Biorad Laboratories Inc.
• Danaher Corporation (News - Alert)
• Hologic
• Roche Diagnostics
• Siemens Healthcare Diagnostics
• Thermo Fischer Scientific Inc.

For more information about this report visit https://www.researchandmarkets.com/research/sprhjg/canada_invitro

View source version on businesswire.com: http://www.businesswire.com/news/home/20170929005609/en/

[ Back To TMCnet.com's Homepage ]